Wednesday Apr 16
SymBio Pharmaceuticals Limited (4582) - Financial and Strategic SWOT...
The company develops drug candidates to target the underserved medical needs in the therapeutic areas of autoimmune, oncology and hematology diseases.
Wednesday Apr 16
Pyridoxine-doxylamine drug safety data lacking
The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research out of St. Michael's Hospital The drug pyridoxine-doxylamine is so popular that it has been prescribed in 33 million women worldwide.
Did bulimia kill Peaches Geldof?
London: Model and TV presenter Peaches Geldof may have had an eating disorder when she died, said doctor Chris Steele.
Can ginger ameliorate chemotherapy-induced nausea? Protocol of a...
Preliminary research shows ginger may be an effective adjuvant treatment for chemotherapy-induced nausea and vomiting but significant limitations need to be addressed before recommendations for clinical practice can be made.
Peaches Geldof 'may have had eating disorder' when she died says top TV doc
Dr Chris Steele said bulimia-related vomiting can create toxic levels of potassium in the body that can cause severe heart irregularities or even cardiac arrest He fears tiny tell-tale signs he has picked out from snaps of her - including the state of her hands - could be interpreted as bulimia.
Heron Therapeutics Initiates Phase 3 Label Expansion Study of SUSTOLa
Heron Therapeutics, Inc. , a specialty pharmaceutical company, today announced the initiation of a Phase 3 clinical trial of SUSTOL , the Company's lead product candidate for the prevention of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic chemotherapy.